New York’s Etain Acquired For $257 Million By RIV Capital, Backed By Scott’s Miracle-GroApril 5, 2022
RIV Capital, a Toronto-based cannabis investment and acquisition firm backed by Scott’s Miracle-Gro, has agreed to acquire New York cannabis company Etain for $257 million. Etain is one of New York State’s original five medical license recipients and one of only 10 approved vertically integrated operators. Based in Chestertown, New York, where it’s expanding its growing and manufacturing space, it operates four dispensaries in Manhattan, Kingston, Syracuse, and Westchester.
Under the terms of the deal, RIV will pay approximately $212 in cash and $35 million in RIV shares. Etain’s owners will also be entitled to nominate a member to RIV’s board, which is expected to be Etain CEO Amy Peckham. RIV also named Mark Sims as its president and CEO to lead the company’s formal entry into the U.S. market and expansion into New York operations. Sims was previously senior vice president of strategy and M&A for Scotts Miracle-Gro.—Danny SullivanSubscribe to Shanken News Daily’s Email Newsletter, delivered to your inbox each morning. You will also receive the Cannabis edition as part of your subscription.
Tagged : cannabis, Etain, RIV Capital, Scotts Miracle-Gro
GET YOUR FIRST LOOK AT 2021 DATA AND 2022 PROJECTIONS FOR THE WINE AND SPIRITS INDUSTRIES. ORDER YOUR 2022 IMPACT DATABANK REPORTS. CLICK HERE.